好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Pseudotumor Cerebri

Saturday 04/16/11
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Victoria S. Pelak, MD, FAAN
Participants should be able to recognize the common clinical manifestations of pseudotumor cerebri; select the appropriate laboratory, neuroimaging, ophthalmic, and other studies needed to diagnose and follow patients with this disorder; list commonly encountered secondary causes of pseudotumor cerebri; understand the indications, benefits, and limitations of currently used medical, interventional, and surgical treatments; and identify challenges in the diagnosis and treatment of pseudotumor cerebri.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Trainee, General Neurologist, Non-neurologist
Case-based, Didactic, Audience Participation
Event Timeline
06:30 AM - 07:00 AM Pseudotumor Cerebri Basics
Victoria S. Pelak, MD, FAAN
06:30 AM - 08:30 AM Break
07:00 AM - 07:30 AM Pseudotumor Treatment Principles
Peter A. Quiros, MD
07:30 AM - 07:40 AM Break
07:40 AM - 08:15 AM Presentation of Cases with Audience Participation
Victoria S. Pelak, MD, FAAN, Peter A. Quiros, MD
08:15 AM - 08:30 AM Questions and Answers
Faculty Disclosures
Victoria S. Pelak, MD, FAAN Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Pelak has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for North American Neuro-ophthalmology Society. Dr. Pelak has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Pelak has received research support from Biogen. Dr. Pelak has received publishing royalties from a publication relating to health care.
Peter A. Quiros, MD No disclosure on file